Durham, North Carolina
United States
110
2025-04-10
83
2023-02-14
These are the the leading inventors for applications assigned to Parion Sciences, Inc.:
Parion Sciences, Inc. based in Durham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
BIPHENYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS
#2 | 2025-04-03BICYCLIC-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS
#3 | 2021-01-28 ā Patent 11,578,042 granted on 2023-02-143,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
#4 | 2020-02-20AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#5 | 2019-10-103,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS
#6 | 2019-08-08SODIUM CHANNEL BLOCKERS
#7 | 2019-03-21CHLORO-PYRAZINE CARBOXAMIDE DERIVATIVES WITH EPITHELIAL SODIUM CHANNEL BLOCKING ACTIVITY
#8 | 2019-01-31 ā Patent 10,968,233 granted on 2021-04-06Monothiol mucolytic agents
#9 | 2019-01-10 ā Patent 10,233,158 granted on 2019-03-19Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
#10 | 2018-04-26 ā Patent 10,526,292 granted on 2020-01-07Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
#11 | 2018-04-19 ā Patent 10,159,672 granted on 2018-12-25Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
#12 | 2018-04-05SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS
#13 | 2017-12-21 ā Patent 10,246,425 granted on 2019-04-023,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
#14 | 2017-11-23 ā Patent 10,752,597 granted on 2020-08-253,5-diamino-6-chloro-Nā(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
#15 | 2017-11-16 ā Patent 10,071,970 granted on 2018-09-11Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
#16 | 2017-10-26 ā Patent 9,957,238 granted on 2018-05-01Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
#17 | 2017-10-05CHEMICALLY AND METABOLICALLY STABLE DIPEPTIDE POSSESSING POTENT SODIUM CHANNEL BLOCKER ACTIVITY
#18 | 2017-09-21 ā Patent 10,167,266 granted on 2019-01-01Sodium channel blockers
#19 | 2017-09-21 ā Patent 9,856,224 granted on 2018-01-02Stable sodium channel blockers
#20 | 2017-06-01 ā Patent 9,987,443 granted on 2018-06-05Inhaled hypertonic saline delivered by a heated nasal cannula
#21 | 2017-01-26 ā Patent 9,849,129 granted on 2017-12-26Sodium channel blockers for skin disorders
#22 | 2016-11-03 ā Patent 10,526,283 granted on 2020-01-07Prodrugs of dithiol mucolytic agents
#23 | 2016-08-04 ā Patent 10,106,551 granted on 2018-10-23Monothiol mucolytic agents
#24 | 2016-07-07 ā Patent 9,963,427 granted on 2018-05-08Dithiol mucolytic agents
#25 | 2016-05-05 ā Patent 9,878,988 granted on 2018-01-30Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
#26 | 2015-12-31SODIUM CHANNEL BLOCKERS
#27 | 2015-12-31STABLE SODIUM CHANNEL BLOCKERS
#28 | 2015-10-29NOVEL MUCOLYTIC AGENTS
#29 | 2015-10-22 ā Patent 9,695,134 granted on 2017-07-043,5-diamino-6-chloro-N-(n-(4-phenylbutyl)carbamimidoyl)pyrazine-2-carboxamide compounds
#30 | 2015-10-15 ā Patent 9,655,896 granted on 2017-05-23Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
#31 | 2015-06-18 ā Patent 9,586,911 granted on 2017-03-07Arylalkyl- and aryloxyalkyl-substituted epthelial sodium channel blocking compounds
#32 | 2015-06-18 ā Patent 9,102,633 granted on 2015-08-11Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
#33 | 2015-06-04AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#34 | 2015-04-16 ā Patent 10,335,558 granted on 2019-07-02Methods of treatment
#35 | 2015-04-09 ā Patent 9,260,398 granted on 2016-02-16Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
#36 | 2015-02-26 ā Patent 9,346,753 granted on 2016-05-24Dithiol mucolytic agents
#37 | 2014-06-26SODIUM CHANNEL BLOCKERS
#38 | 2014-06-19 ā Patent 9,593,084 granted on 2017-03-14Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
#39 | 2014-06-19 ā Patent 9,029,382 granted on 2015-05-123,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
#40 | 2014-06-12NASAL CANNULA FOR DELIVERY OF AEROSOLIZED MEDICAMENTS
#41 | 2014-05-22 ā Patent 9,072,738 granted on 2015-07-07Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
#42 | 2014-04-24 ā Patent 8,945,605 granted on 2015-02-03Aerosol delivery systems, compositions and methods
#43 | 2014-04-17 ā Patent 9,586,910 granted on 2017-03-073,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
#44 | 2014-04-10 ā Patent 9,408,988 granted on 2016-08-09Inhaled hypertonic saline delivered by a heated nasal cannula
#45 | 2014-01-30POLY AROMATIC SODIUM CHANNEL BLOCKERS
#46 | 2013-12-05 ā Patent 8,980,898 granted on 2015-03-17Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
#47 | 2013-07-11 ā Patent 8,669,262 granted on 2014-03-113,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
#48 | 2013-03-28 ā Patent 8,778,383 granted on 2014-07-15Methods of treatment
#49 | 2013-01-10 ā Patent 8,846,688 granted on 2014-09-30Sodium channel blockers
#50 | 2012-08-30 ā Patent 8,507,497 granted on 2013-08-13Capped pyrazinoylguanidine sodium channel blockers
#51 | 2012-06-28Methods of Reducing Risk of Infection from Pathogens
#52 | 2012-05-10 ā Patent 8,575,176 granted on 2013-11-05Heteroaromatic pyrazinoylguanidine sodium channel blockers
#53 | 2011-08-11CYCLIC SUBSTITUTED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS POSSESSING BETA AGONIST ACTIVITY
#54 | 2011-06-16 ā Patent 8,314,105 granted on 2012-11-20Methods of reducing risk of infection from pathogens
#55 | 2011-02-24 ā Patent 8,431,579 granted on 2013-04-30Capped pyrazinoylguanidine sodium channel blockers
#56 | 2011-01-13 ā Patent 8,163,758 granted on 2012-04-24Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
#57 | 2011-01-06 ā Patent 8,211,895 granted on 2012-07-03Capped pyrazinoylguanidine sodium channel blockers
#58 | 2010-10-21 ā Patent 8,324,218 granted on 2012-12-04Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
#59 | 2010-06-10 ā Patent 8,227,474 granted on 2012-07-24Sodium channel blockers
#60 | 2010-03-25MULTIPLE NEBULIZER SYSTEMS
#61 | 2009-12-31SOLUBLE AMIDE & ESTER PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#62 | 2009-09-10 ā Patent 7,956,059 granted on 2011-06-07Aliphatic amide and ester pyrazinoylguanidine sodium channel blockers
#63 | 2009-09-10 ā Patent 8,198,286 granted on 2012-06-12Sodium channel blockers
#64 | 2009-08-27 ā Patent 8,124,607 granted on 2012-02-28Poly aromatic pyrazinoylguanidine sodium channel blockers
#65 | 2009-04-23 ā Patent 8,551,534 granted on 2013-10-08Inhaled hypertonic saline delivered by a heated nasal cannula
#66 | 2009-03-26 ā Patent 7,981,898 granted on 2011-07-19Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
#67 | 2009-03-19 ā Patent 7,842,697 granted on 2010-11-30Soluble amide and ester pyrazinoylguanidine sodium channel blockers
#68 | 2009-03-05METHODS OF USING SODIUM CHANNEL BLOCKERS
#69 | 2009-01-15CAPPED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#70 | 2008-11-27METHOD OF TREATING ACID-SENSING ION CHANNEL MEDIATED PAIN, COUGH SUPPRESSION, AND CENTRAL NERVOUS SYSTEM DISORDERS
#71 | 2008-10-09 ā Patent 8,288,391 granted on 2012-10-16Pyrazinoylguanidine compounds for use as taste modulators
#72 | 2008-08-21ALAPHATIC PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#73 | 2008-07-24 ā Patent 8,022,210 granted on 2011-09-20Soluble amide and ester pyrazinoylguanidine sodium channel blockers
#74 | 2008-07-24CAPPED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#75 | 2008-07-17 ā Patent 7,868,010 granted on 2011-01-11Capped pyrazinoylguanidine sodium channel blockers
#76 | 2008-07-17 ā Patent 8,008,494 granted on 2011-08-30Soluble amide and ester pyrazinoylguanidine sodium channel blockers
#77 | 2008-07-10CAPPED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#78 | 2008-05-06 ā Patent 7,368,450 granted on 2008-05-06Sodium channel blockers
#79 | 2008-05-01CYCLIC PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
#80 | 2008-04-24 ā Patent 8,143,256 granted on 2012-03-27Cyclic amide and ester pyrazinoylguanidine sodium channel blockers
#81 | 2008-04-17 ā Patent 8,058,278 granted on 2011-11-15Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
#82 | 2008-03-27 ā Patent 7,820,678 granted on 2010-10-26Sodium channel blockers
#83 | 2008-02-19 ā Patent 7,332,496 granted on 2008-02-19Methods of using sodium channel blockers
#84 | 2007-11-15METHODS OF USING SODIUM CHANNEL BLOCKERS
#85 | 2007-07-24 ā Patent 7,247,636 granted on 2007-07-24Phenolic guanidine sodium channel blockers
#86 | 2007-07-10 ā Patent 7,241,766 granted on 2007-07-10Methods of using phenolic guanidine sodium channel blockers
#87 | 2007-03-20 ā Patent 7,192,960 granted on 2007-03-20Sodium channel blockers
#88 | 2007-03-20 ā Patent 7,192,959 granted on 2007-03-20Sodium channel blockers
#89 | 2007-03-20 ā Patent 7,192,958 granted on 2007-03-20Sodium channel blockers
#90 | 2007-03-13 ā Patent 7,189,719 granted on 2007-03-13Sodium channel blockers
#91 | 2007-03-06 ā Patent 7,186,833 granted on 2007-03-06Sodium channel blockers
#92 | 2007-02-08 ā Patent 7,807,834 granted on 2010-10-05Capped pyrazinoylguanidine sodium channel blockers
#93 | 2006-09-14 ā Patent 7,410,968 granted on 2008-08-12Capped pyrazinoylguanidine sodium channel blockers
#94 | 2006-06-29 ā Patent 7,875,619 granted on 2011-01-25Hetero substituted sodium channel blockers
#95 | 2006-03-23 ā Patent 7,345,044 granted on 2008-03-18Sodium channel blockers
#96 | 2006-03-09 ā Patent 7,368,451 granted on 2008-05-06Capped pyrazinoylguanidine sodium channel blockers
#97 | 2006-03-09 ā Patent 7,368,447 granted on 2008-05-06Capped pyrazinoylguanidine sodium channel blockers
#98 | 2006-02-23 ā Patent 7,399,766 granted on 2008-07-15Soluble amide & ester pyrazinoylguanidine sodium channel blockers
#99 | 2005-10-20 ā Patent 7,247,637 granted on 2007-07-24Capped pyrazinoylguanidine sodium channel blockers
#100 | 2005-10-13 ā Patent 7,388,013 granted on 2008-06-17Capped pyrazinoylguanidine sodium channel blockers
Also check out Parion Sciences, Inc.'s (Durham, United States) applicant profile with 32 patent applications submitted.
3751 ā